[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cd8b-wt-allele":3},{"name":4,"total":5,"recruiting":6,"trials":7},"CD8B wt Allele",4,2,[8,16,23,30],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05592015","Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia",[12],"Phase 2","RECRUITING","2026-08-26T02:15:26.669629Z","2026-05-05T02:43:28.203289Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05475925","A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas",[20],"Phase 1\u002FPhase 2","2026-08-26T02:15:28.524219Z","2026-05-05T02:43:27.068416Z",{"nct_id":24,"title":25,"phases":26,"status":27,"updated_at":28,"content_modified":29},"NCT07682792","Golidocitinib in Patients With Mycosis Fungoides\u002FSézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia",[12],"NOT_YET_RECRUITING","2026-08-26T02:19:16.454910Z","2026-07-19T19:36:05.150066Z",{"nct_id":31,"title":32,"phases":33,"status":35,"updated_at":36,"content_modified":37},"NCT06495593","Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis",[34],"Phase 4","ENROLLING_BY_INVITATION","2026-08-26T02:17:39.048487Z","2026-06-16T05:54:07.757786Z"]